These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34002203)

  • 1. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Navarese EP; Lansky AJ; Kereiakes DJ; Kubica J; Gurbel PA; Gorog DA; Valgimigli M; Curzen N; Kandzari DE; Bonaca MP; Brouwer M; Umińska J; Jaguszewski MJ; Raggi P; Waksman R; Leon MB; Wijns W; Andreotti F
    Eur Heart J; 2021 Dec; 42(45):4638-4651. PubMed ID: 34002203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
    Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials.
    Kowalewski M; Schulze V; Berti S; Waksman R; Kubica J; Kołodziejczak M; Buffon A; Suryapranata H; Gurbel PA; Kelm M; Pawliszak W; Anisimowicz L; Navarese EP
    Heart; 2015 Aug; 101(16):1309-17. PubMed ID: 26037102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality: A Meta-Analysis.
    Navarese EP; Lansky AJ; Farkouh ME; Grzelakowska K; Bonaca MP; Gorog DA; Raggi P; Kelm M; Yeo B; Umińska J; Curzen N; Kubica J; Wijns W; Kereiakes DJ
    JACC Cardiovasc Interv; 2023 May; 16(10):1144-1156. PubMed ID: 37225285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.
    Ibbotson T; McGavin JK; Goa KL
    Drugs; 2003; 63(11):1121-63. PubMed ID: 12749745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
    Laukkanen JA; Kunutsor SK
    Int J Cardiol; 2021 Feb; 324():13-21. PubMed ID: 33068645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.
    Windecker S; Stortecky S; Stefanini GG; da Costa BR; Rutjes AW; Di Nisio M; Silletta MG; Maione A; Alfonso F; Clemmensen PM; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head S; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter D; Schauerte P; Sousa Uva M; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A; Kolh P; Jüni P
    BMJ; 2014 Jun; 348():g3859. PubMed ID: 24958153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-vessel versus multivessel revascularisation in ST-elevation myocardial infarction: a meta-analysis of randomised trials.
    Sarathy K; Nagaraja V; Kapur A; Szirt R; Raval J; Eslick GD; Burgess D; Denniss AR
    Heart Lung Circ; 2015 Apr; 24(4):327-34. PubMed ID: 25547531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
    Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
    J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-based rehabilitation for coronary heart disease.
    Jolliffe JA; Rees K; Taylor RS; Thompson D; Oldridge N; Ebrahim S
    Cochrane Database Syst Rev; 2000; (4):CD001800. PubMed ID: 11034729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Cavalcante R; Sotomi Y; Zeng Y; Lee CW; Ahn JM; Collet C; Tenekecioglu E; Suwannasom P; Onuma Y; Park SJ; Serruys PW
    Heart; 2017 Mar; 103(6):428-433. PubMed ID: 27651390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.
    Stone GW; Gao R; Kimura T; Kereiakes DJ; Ellis SG; Onuma Y; Cheong WF; Jones-McMeans J; Su X; Zhang Z; Serruys PW
    Lancet; 2016 Mar; 387(10025):1277-89. PubMed ID: 26825231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
    Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
    Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
    Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.
    Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA
    JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.